Kuala Lumpur - Delayed Quote MYR
Pharmaniaga Berhad (7081.KL)
0.2500
-0.0100
(-3.85%)
At close: 4:53:47 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,759,479
3,759,479
3,404,481
3,480,935
4,815,015
Cost of Revenue
3,218,985
3,218,985
3,096,660
3,690,523
4,185,000
Gross Profit
540,494
540,494
307,821
-209,588
630,015
Operating Expense
279,568
279,568
328,267
314,385
322,302
Operating Income
260,926
260,926
-20,446
-523,973
307,713
Net Non Operating Interest Income Expense
-69,717
-69,717
-60,366
-39,128
-31,801
Pretax Income
194,180
194,180
-78,163
-610,588
277,075
Tax Provision
60,386
60,386
581
17,066
104,870
Net Income Common Stockholders
131,822
131,822
-80,160
-629,921
172,150
Diluted NI Available to Com Stockholders
131,822
131,822
-80,160
-629,921
172,150
Basic EPS
0.06
0.09
-0.06
-0.48
0.13
Diluted EPS
0.06
0.09
-0.06
-0.48
0.13
Basic Average Shares
1,441,430.7500
1,441,229
1,367,642
1,309,971
1,309,336
Diluted Average Shares
1,441,430.7500
1,441,229
1,367,642
1,309,971
1,309,336
Total Expenses
3,498,553
3,498,553
3,424,927
4,004,908
4,507,302
Net Income from Continuing & Discontinued Operation
131,822
131,822
-80,160
-629,921
172,150
Normalized Income
131,822
131,822
-80,160
-591,751.5200
172,105.8728
Interest Income
2,252
2,252
1,477
910
1,523
Interest Expense
71,969
71,969
61,843
40,038
33,324
Net Interest Income
-69,717
-69,717
-60,366
-39,128
-31,801
EBIT
266,149
266,149
-16,320
-570,550
310,399
EBITDA
266,149
266,149
-16,320
-570,550
310,399
Reconciled Cost of Revenue
3,218,985
3,218,985
3,096,660
3,690,523
4,185,000
Net Income from Continuing Operation Net Minority Interest
131,822
131,822
-80,160
-629,921
172,150
Total Unusual Items Excluding Goodwill
--
--
864
-50,223
71
Total Unusual Items
--
--
864
-50,223
71
Normalized EBITDA
266,149
266,149
-16,320
-520,327
310,328
Tax Rate for Calcs
0.0003
0.0003
0.0002
0.0002
0.0004
Tax Effect of Unusual Items
--
--
--
-12,053.5200
26.8728
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade